Mitchell Sinkler & Starr’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Mitchell Sinkler & Starr's AMGN Position: Q3 2026 in Review
Mitchell Sinkler & Starr increased its Amgen (AMGN) stake by 0.65% in Q3 2026, buying an estimated $5.98K and bringing the position to 2,310 shares worth $974K. The position accounts for 0.39% of the portfolio, ranked #54.
Mitchell Sinkler & Starr first reported a position in AMGN in Q1 2023 and has held it in 15 quarters since. The position peaked at $1.32M in Q2 2024. 965 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Mitchell Sinkler & Starr held 2,310 shares of Amgen worth $974K as of Q3 2026.
- Mitchell Sinkler & Starr bought 15 Amgen shares in Q3 2026, an estimated $5.98K.
- Amgen made up 0.39% of Mitchell Sinkler & Starr's portfolio in Q3 2026, its #54 holding.
- Mitchell Sinkler & Starr first reported a position in Amgen in Q1 2023 and has held it in 15 quarters since.
- Mitchell Sinkler & Starr's Amgen position peaked at $1.32M in Q2 2024.
- 965 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Mitchell Sinkler & Starr's 13F filing for Q3 2026, filed 13 Oct 2026.